Current Neuropharmacology
Title:Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders)
Volume: 14 Issue: 6
Author(s): Ashutosh Kumar
Affiliation:
Export Options
About this article
Cite this article as:
Kumar Ashutosh, Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders), Current Neuropharmacology 2016; 14 (6) . https://dx.doi.org/10.2174/1570159X1406160627150804
DOI https://dx.doi.org/10.2174/1570159X1406160627150804 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can γH2AX be Used to Personalise Cancer Treatment?
Current Molecular Medicine Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Editorial (Thematic Issue: Chemical and Biological Technology for In Vivo and Molecular Imaging)
Current Topics in Medicinal Chemistry Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design Interleukin-7: a key Mediator in T Cell-driven Autoimmunity, Inflammation, and Tissue Destruction
Current Pharmaceutical Design Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Current Pharmaceutical Biotechnology The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
Current Pharmaceutical Design Targeting the BRCA1/2 Tumor Suppressors
Current Drug Targets CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Patent Selections
Recent Patents on Drug Delivery & Formulation Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas
Recent Patents on CNS Drug Discovery (Discontinued) Astatine Radiopharmaceuticals: Prospects and Problems
Current Radiopharmaceuticals Boron Nitride Nanotubes: Production, Properties, Biological Interactions and Potential Applications as Therapeutic Agents in Brain Diseases
Current Nanoscience Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Passive Targeting of Cyclophosphamide-Loaded Carbonate Apatite Nanoparticles to Liver Impedes Breast Tumor Growth in a Syngeneic Model
Current Pharmaceutical Design Glutamate Receptor Agonists: Stereochemical Aspects
Current Topics in Medicinal Chemistry Combination of Phytochemicals as Adjuvants for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery New Framework for the Discovery of PRC2 Inhibitors: Epigenetic Drugs
Current Drug Targets